PL1824493T3 - Zawiesina zawierająca meloksykam do podawania doustnego - Google Patents
Zawiesina zawierająca meloksykam do podawania doustnegoInfo
- Publication number
- PL1824493T3 PL1824493T3 PL05850431T PL05850431T PL1824493T3 PL 1824493 T3 PL1824493 T3 PL 1824493T3 PL 05850431 T PL05850431 T PL 05850431T PL 05850431 T PL05850431 T PL 05850431T PL 1824493 T3 PL1824493 T3 PL 1824493T3
- Authority
- PL
- Poland
- Prior art keywords
- meloxicam
- oral suspension
- pain
- acute
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04106318 | 2004-12-06 | ||
EP05850431A EP1824493B1 (en) | 2004-12-06 | 2005-12-02 | Oral suspension comprising meloxicam |
PCT/EP2005/056419 WO2006061351A1 (en) | 2004-12-06 | 2005-12-02 | Oral suspension comprising meloxicam |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1824493T3 true PL1824493T3 (pl) | 2009-01-30 |
Family
ID=34929998
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL05850431T PL1824493T3 (pl) | 2004-12-06 | 2005-12-02 | Zawiesina zawierająca meloksykam do podawania doustnego |
Country Status (14)
Country | Link |
---|---|
US (1) | US7705000B2 (pl) |
EP (1) | EP1824493B1 (pl) |
JP (1) | JP2008523024A (pl) |
AT (1) | ATE404206T1 (pl) |
AU (1) | AU2005313365A1 (pl) |
CA (1) | CA2586288A1 (pl) |
DE (1) | DE602005009016D1 (pl) |
DK (1) | DK1824493T3 (pl) |
ES (1) | ES2313452T3 (pl) |
NO (1) | NO20073419L (pl) |
PL (1) | PL1824493T3 (pl) |
PT (1) | PT1824493E (pl) |
TW (1) | TW200635598A (pl) |
WO (1) | WO2006061351A1 (pl) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1568369A1 (en) | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
EP2034958B1 (en) * | 2006-05-19 | 2009-10-28 | Norbrook Laboratories Limited | Stable aqueous suspension having palatable taste |
GB2438287A (en) * | 2006-05-19 | 2007-11-21 | Norbrook Lab Ltd | Stable aqueous suspension |
WO2008009664A2 (en) * | 2006-07-19 | 2008-01-24 | Boehringer Ingelheim International Gmbh | Treatment of pain |
FR2911506B1 (fr) * | 2007-01-18 | 2009-07-03 | Ceva Sante Animale Sa | Compositions pharmaceutiques destinees a une administration par voie orale sous forme de suspensions aqueuses stabilisees |
US8999395B2 (en) | 2007-02-09 | 2015-04-07 | Ceva Sante Animale | Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions |
US20150231156A1 (en) * | 2007-11-13 | 2015-08-20 | Meritage Pharma, Inc. | Corticosteroid compositions |
US20110212948A1 (en) * | 2008-09-05 | 2011-09-01 | Giuseppe Pippia | Treatment of neonate foals with meloxicam |
DK2488145T3 (da) * | 2009-10-12 | 2024-07-22 | Boehringer Ingelheim Vetmedica Gmbh | Beholdere til sammensætninger omfattende meloxicam |
GB201006218D0 (en) * | 2010-04-14 | 2010-06-02 | Ayanda As | Composition |
GB201117858D0 (en) * | 2011-10-17 | 2011-11-30 | Norbrook Lab Ltd | Paste |
PL239019B1 (pl) * | 2017-07-14 | 2021-10-25 | Aflofarm Farm Polska Spolka Z Ograniczona Odpowiedzialnoscia | Kompozycja farmaceutyczna w postaci wodnego roztworu, korzystnie syropu, zawierająca pranobeks inozyny oraz glukonianu cynku oraz jej sposób otrzymywania |
BR112020001907A2 (pt) * | 2017-08-24 | 2020-08-04 | Jiangsu Hengrui Medicine Co., Ltd. | composição farmacêutica injetável contendo meloxicam, e seu método de preparação |
US20210106591A1 (en) * | 2018-05-11 | 2021-04-15 | Nanjing Delova Biotech Co. Ltd. | Meloxicam composition, preparation and preparation method and use thereof |
JP2021527097A (ja) * | 2018-06-15 | 2021-10-11 | ヤンセン ファーマシューティカ エヌ.ベー. | イブルチニブを含む配合物/組成物 |
GB2585825B (en) * | 2019-07-09 | 2023-03-22 | Lexon Uk Holdings Ltd | Suspending vehicle formulation |
KR102530032B1 (ko) | 2019-09-18 | 2023-05-09 | 정원구 | 반려동물용 현탁액 조성물 및 이의 제조방법 |
CN113143863A (zh) * | 2020-01-22 | 2021-07-23 | 浙江贝灵生物医药有限公司 | 一种口服溶媒组合物及其制备方法与应用 |
CN112587497A (zh) * | 2020-12-25 | 2021-04-02 | 苏州中化药品工业有限公司 | 一种美洛昔康混悬液胶囊剂及其制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ234143A (en) * | 1989-06-28 | 1991-10-25 | Mcneil Ppc Inc | Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents |
US5272137A (en) | 1992-02-14 | 1993-12-21 | Mcneil-Pfc, Inc. | Aqueous pharmaceutical suspension for pharmaceutical actives |
IT1286496B1 (it) * | 1996-11-20 | 1998-07-15 | Leetrim Ltd Dublin | Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria |
ZA987800B (en) | 1997-08-27 | 1999-06-09 | Hexal Ag | Pharmaceutical composition of meloxicam |
EP0945134A1 (de) | 1998-03-27 | 1999-09-29 | Boehringer Ingelheim Pharma KG | Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation |
EP0945131A1 (de) * | 1998-03-27 | 1999-09-29 | Boehringer Ingelheim Pharma KG | Perorale Wirkstoff-Suspension |
EP1082966A4 (en) | 1998-05-15 | 2004-07-21 | Wakamoto Pharma Co Ltd | ANTI-INFLAMMATORY EYE DROPS |
DE10030345A1 (de) * | 2000-06-20 | 2002-01-10 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen |
EP1411900B2 (en) * | 2001-06-01 | 2013-12-04 | Pozen, Inc. | PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs |
US7666876B2 (en) * | 2002-03-19 | 2010-02-23 | Vernalis (R&D) Limited | Buprenorphine formulations for intranasal delivery |
JP2004131495A (ja) * | 2002-09-17 | 2004-04-30 | Nippon Boehringer Ingelheim Co Ltd | 非ステロイド系抗炎症剤の局所送達用医薬組成物 |
US20050095299A1 (en) * | 2003-10-30 | 2005-05-05 | Wynn David W. | Controlled release analgesic suspensions |
-
2005
- 2005-12-02 PL PL05850431T patent/PL1824493T3/pl unknown
- 2005-12-02 PT PT05850431T patent/PT1824493E/pt unknown
- 2005-12-02 AU AU2005313365A patent/AU2005313365A1/en not_active Abandoned
- 2005-12-02 DE DE602005009016T patent/DE602005009016D1/de active Active
- 2005-12-02 WO PCT/EP2005/056419 patent/WO2006061351A1/en active IP Right Grant
- 2005-12-02 EP EP05850431A patent/EP1824493B1/en not_active Revoked
- 2005-12-02 JP JP2007544887A patent/JP2008523024A/ja active Pending
- 2005-12-02 CA CA002586288A patent/CA2586288A1/en not_active Abandoned
- 2005-12-02 AT AT05850431T patent/ATE404206T1/de active
- 2005-12-02 ES ES05850431T patent/ES2313452T3/es active Active
- 2005-12-02 DK DK05850431T patent/DK1824493T3/da active
- 2005-12-02 US US11/720,869 patent/US7705000B2/en not_active Expired - Fee Related
- 2005-12-05 TW TW094142716A patent/TW200635598A/zh unknown
-
2007
- 2007-07-03 NO NO20073419A patent/NO20073419L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DK1824493T3 (da) | 2008-12-08 |
EP1824493A1 (en) | 2007-08-29 |
AU2005313365A1 (en) | 2006-06-15 |
EP1824493B1 (en) | 2008-08-13 |
US20090221563A1 (en) | 2009-09-03 |
DE602005009016D1 (de) | 2008-09-25 |
US7705000B2 (en) | 2010-04-27 |
CA2586288A1 (en) | 2006-06-15 |
NO20073419L (no) | 2007-07-03 |
JP2008523024A (ja) | 2008-07-03 |
TW200635598A (en) | 2006-10-16 |
ATE404206T1 (de) | 2008-08-15 |
PT1824493E (pt) | 2008-11-18 |
WO2006061351A1 (en) | 2006-06-15 |
ES2313452T3 (es) | 2009-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1824493T3 (pl) | Zawiesina zawierająca meloksykam do podawania doustnego | |
MX2007005870A (es) | Composiciones que comprenden derivados de escilo-inositol y metodos para tratar trastornos de agregacion de proteinas. | |
MXPA06014510A (es) | Composiciones y metodos para tratar trastornos inflamatorios. | |
WO2004075832A3 (en) | Methods and compositions for the treatment of chronic pain using dhea and derivatives thereof | |
HK1108442A1 (en) | Rapamcyin analogues and the uses thereof in the treatment of neurological, proliferative and inflammatory disorders | |
MXPA04003666A (es) | Uso de flibanserina para tratamiento de trastornos sexuales. | |
WO2006119958A3 (en) | Use of flibanserin in the treatment of chronic pain | |
ZA200807879B (en) | Use of bifidobacterium longum for the prevention and treatment of inflammation | |
IL178775A (en) | Pharmaceuticals containing glucocorticoid for use in the treatment of disorders requiring acute glucocorticoid therapy | |
IL201479A (en) | Use of tapentadol for the preparation of pain medication | |
IL182222A0 (en) | Treatment of bipolar disorders and associated symptoms | |
WO2005115547A3 (en) | Myricitrin compounds for sleeping disorders | |
EP1888091A4 (en) | USE OF MAIN OLEOCANTHAL IRRIGATION IN OLIVE OIL AND STRUCTURALLY AND FUNCTIONALLY SIMILAR COMPONENTS | |
WO2006122123A3 (en) | Methods of alleviating disorders and their associated pain | |
TW200509896A (en) | Analeptic and drug combinations | |
TWI372047B (en) | Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same | |
ZA200400313B (en) | Use of BIBN4096 in combination with other antimigraine drugs for the treatment of migraine. | |
WO2005113814A3 (en) | Biomarkers of chronic pelvic pain syndrome | |
CA115335S (en) | Massage chair | |
IL179636A0 (en) | Combination therapy with radiolabeled anti-cd20 antibody in the treatment of b-cell lymphoma | |
CA118871S (en) | Bicycle brake pad | |
CA115340S (en) | Massage chair | |
WO2010129788A3 (en) | Uses of cationic hydroxythylcellulose in oral ingestion forms, and prevention and treatment of metabolic disorders | |
WO2009108297A3 (en) | Combination therapy for treatment of bone and mineral disorders for patients with impaired renal function | |
CA115333S (en) | Massage chair |